Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00FIE
|
|||
Former ID |
DNC010925
|
|||
Drug Name |
2-(2-Hydroxyethyl)anthra[1,9-cd]pyrazol-6(2H)-one
|
|||
Synonyms |
SCHEMBL11120339
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H12N2O2
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C3=NN(C4=CC=CC(=C43)C2=O)CCO
|
|||
InChI |
1S/C16H12N2O2/c19-9-8-18-13-7-3-6-12-14(13)15(17-18)10-4-1-2-5-11(10)16(12)20/h1-7,19H,8-9H2
|
|||
InChIKey |
IWTWHJYONHLOQB-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | DNA topoisomerase II (TOP2) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Design, synthesis and biological evaluation of a novel series of anthrapyrazoles linked with netropsin-like oligopyrrole carboxamides as anticancer... Bioorg Med Chem. 2010 Jun 1;18(11):3974-84. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.